Home » News » Press Releases
NEW PROJECT MANAGEMENT TOOL QUICKLY DIAGNOSES PROBLEM PROGRAMS
p3 Needs Analysis© From Integrated Project Management, Co., Inc. Identifies Project Difficulties; Delivers Solution For Recovery
Burr Ridge, Ill., (July 9, 2003) - A new tool that delivers a quick and economical diagnosis of problems with an individual project, a collective program, or an entire portfolio of strategic initiatives is now available from Integrated Project Management Co., Inc. (IPM). The p3 (project, program, portfolio) Needs Analysis© product not only identifies the problems inhibiting project, program, or portfolio success, it delivers a practical and actionable strategy to get these initiatives back on track.
"It's no secret that many industries are asking more critical questions about performance in light of current economic conditions," observes Mark Jablonski, vice president, business development for IPM. "The p3 Needs Analysis© is a regular component in many of IPM's traditional project management assignments. Breaking it out as a stand-alone product is in direct demand from companies looking for expert help through a quick, economical engagement to identify how to return their initiatives to the right course."
The p3 Needs Analysis© brings together IPM's extensive project execution experience and best practice project management methods to root out and eliminate the obstacles that hinder initiatives from succeeding. The product takes customer initiatives through a three-step process:
- Discovery and Characterization establishes a baseline understanding of the current condition and desired outcome for the initiative.
- Gap Analysis and Prioritization diagnoses the problems and their relative severity.
- Solution Strategy Development identifies the specific changes that must be implemented to get the initiative back on track.
Depending on the scope of the assignment, a p3 Needs Analysis© can deliver the answers companies need in as little as four weeks.
# # #
Integrated Project Management Company, Inc. (IPM) (www.ipmcinc.com) redefines the value of project management for leading companies worldwide in the pharmaceutical, biotechnology, medical device, industrial products, and consumer products industries.
Since 1988, IPM has collaborated with its clients, including Pfizer, S.C. Johnson & Son, Johnson & Johnson, and BP, among others, to improve project, program, and portfolio execution through a unique blend of professional project management and business management consulting expertise in product development, manufacturing, strategic planning, business process optimization, information technology, and site, facilities, and infrastructure.
Through IPM's performance, uncompromising integrity, and commitment, its clients have benefited from more consistent project, program, and portfolio performance that lead to significant and measurable improvements in financial returns on investment, organizational effectiveness, and market competitiveness.
Editor's Note:
For more information, please contact:
Mark E. Jablonski, Vice President, Business Development
Integrated Project Management Company, Inc.
200 S. Frontage Road, Suite 220, Burr Ridge, IL 60527
Telephone: (630) 789-8600 or email:
Or, contact:
Robert A. ReedS. Duensing & Associates, Inc.
Telephone: (630) 579-1770 or email:
